Literature DB >> 18459519

Psoriasis: cardiovascular risk factors and other disease comorbidities.

Ying Wu1, Douglas Mills, Mohan Bala.   

Abstract

The risk factors of cardiovascular disease and other disease comorbidities appear to be more common in patients with psoriasis compared with the general population. To support this concept, the association between psoriasis and cardiovascular disease and other comorbidities was analyzed using data collected from 40 730 patients in the National Health and Wellness Survey (NHWS) during May and June 2004. A case-control study was conducted with data from 1127 patients with psoriasis and a matched cohort of nonpsoriasis patients. Psoriasis patients were significantly more likely to have cardiovascular comorbidities, including hypertension, hypercholesterolemia, and diabetes, compared with nonpsoriasis patients. Other comorbidities significantly associated with psoriasis were arthritis, depression, sleep disorder/insomnia, chronic obstructive pulmonary disease, and gastroesophageal reflux disease. Responses to this large survey confirm that patients with psoriasis have a higher rate of cardiovascular risk factors and other comorbidities compared with patients without psoriasis.

Entities:  

Mesh:

Year:  2008        PMID: 18459519

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  22 in total

1.  Sleep Quality and its Association with Disease Severity in Psoriasis.

Authors:  Mehmet Melikoglu
Journal:  Eurasian J Med       Date:  2017-06

Review 2.  Fumaric acid esters for psoriasis: a systematic review.

Authors:  D Smith
Journal:  Ir J Med Sci       Date:  2016-06-07       Impact factor: 1.568

3.  Malaysian Clinical Practice Guideline for the Management of Psoriasis Vulgaris: Summary of recommendations for management in primary healthcare setting.

Authors:  Se Choon; Lc Chan; Siew Eng Choon; Adawiyah Jamil; Chan Lee Chin; Chong Hwee Cheng; Dawn Ambrose; Hazreen Abdul Majid; Koh Chang Heng; Loh Yet Lin; Mohd Aminuddin Mohd Yusof; Sin Lian Thye; Suganthi Thevarajah; Suriati Hashim; Tang Jyhe Jong; Wong Su Ming; Yunus Shariff
Journal:  Malays Fam Physician       Date:  2014-04-30

4.  Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women.

Authors:  Shaowei Wu; Wen-Qing Li; Jiali Han; Qi Sun; Abrar A Qureshi
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

5.  Might psoriasis be a risk factor for obstructive sleep apnea syndrome?

Authors:  Semsettin Karaca; Fatma Fidan; Faruk Erkan; Serkan Nural; Tulay Pinarcı; Ersin Gunay; Mehmet Unlu
Journal:  Sleep Breath       Date:  2012-03-15       Impact factor: 2.816

Review 6.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

7.  Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis.

Authors:  E D Dommasch; D B Shin; A B Troxel; D J Margolis; J M Gelfand
Journal:  Br J Dermatol       Date:  2009-11-10       Impact factor: 9.302

8.  Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.

Authors:  Malgorzata Romanowska; Louise Reilly; Colin N A Palmer; Mattias C U Gustafsson; John Foerster
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

9.  Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.

Authors:  Yves Poulin; Norman Wasel; Daphne Chan; Geula Bernstein; Robin Andrew; Elisa Fraquelli; Kim Papp
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

10.  Mechanisms of action of topical corticosteroids in psoriasis.

Authors:  Luís Uva; Diana Miguel; Catarina Pinheiro; Joana Antunes; Diogo Cruz; João Ferreira; Paulo Filipe
Journal:  Int J Endocrinol       Date:  2012-11-05       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.